Neonatal management and outcome in alloimmune hemolytic disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neonatal management and outcome in alloimmune hemolytic disease

Published:2017-06-05 Issue:7 Volume:10 Page:607-616
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Ree Isabelle M. C.¹²,Smits-Wintjens Vivianne E. H. J.¹,van der Bom Johanna G.²,van Klink Jeanine M. M.¹,Oepkes Dick³,Lopriore Enrico¹

Affiliation:

1. Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands

2. Sanquin Blood Supply, Clinical Transfusion Research, Leiden, Zuid-Holland, The Netherlands

3. Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1331124

Reference99 articles.

1. Haemolytic disease of the fetus and newborn

2. RhD haemolytic disease of the fetus and the newborn

3. Fetal anemia due to non-Rhesus-D red-cell alloimmunization

4. Thirty-five years of Rh prophylaxis

5. One single dose of 200 μg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RhD-Alloimmunization in Adult and Pediatric Trauma Patients;Transfusion Medicine Reviews;2024-10

2. Management and Treatment Outcomes of Hemolytic Disease of the Fetus and Newborn (HDFN)—A Retrospective Cohort Study;Journal of Clinical Medicine;2024-08-14

3. Hemolytic disease of fetus and newborn course, management and outcomes - an analysis based on the Israeli Maccabi database;2024-07-19

4. Does high body mass index (>25 kg/m²) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis;Vox Sanguinis;2024-06-18

5. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study;Journal of Clinical Medicine;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3